Also interesting
![Takeda announcement investment LR](https://www.kickstartbiomanufacturing.be/assets/uploads/site/takeda-invests-close-to-300-million-euros-in-its-plasma-derived-therapies-production-site-in-lessines/_767x490_crop_center-center_95_none/Takeda-announcement-investment_LR.jpg)
Takeda Invests Close to 300 Million Euros in its Plasma-Derived Therapies Production Site in Lessines
The investment encompasses a new production facility and a carbon net-zero emissions warehouse.
![650bd4b8a58539c243eb753066bd6b17 jpg](https://www.kickstartbiomanufacturing.be/assets/uploads/site/cellistics-platform-enables-faster-allogeneic-cell-therapies-manufacturing/_767x490_crop_center-center_95_none/650bd4b8a58539c243eb753066bd6b17-jpg.webp)
Cellistic's platform enables faster allogeneic cell therapies manufacturing
Cellistic's first off-the-shelf, pre-built cell line and iPSC-based manufacturing platforms enable faster and cheaper allogeneic cell therapies development.
![Gsk and imec hero](https://www.kickstartbiomanufacturing.be/assets/uploads/site/_767x490_crop_center-center_95_none/gsk-and-imec-hero.jpeg)
GSK and imec to collaborate on disruptive innovation in pharma
A collaboration between GSK, a multinational pharma company whose vaccines headquarters are in Wallonia, and imec, a leading nanoelectronics research centre based in Flanders, is bringing together in Belgium two of its most innovative sectors...